Lycera Corp.

ACTIVE

620 W Germantown Pike, 密歇根州沃什特瑙县, 密歇根州, United Stateswww.lycera.comPrivate51–100 employeesEstablished: 2006-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

50.0%

Trial Status Distribution

Completed

66.7%

Terminated

16.7%

Unknown

16.7%

Clinical Trials

Trials sponsored by this organization (6)

Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer

Phase 1

Unknown

interventional

Aug 201817 participants

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

Phase 2

Completed

interventional

Dec 201633 participants

Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer

Phase 1

Completed

interventional

Dec 2016119 participants

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Phase 2

Terminated

interventional

Nov 2016112 participants

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Phase 2

Completed

interventional

Jul 2016124 participants

Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis

Phase 1

Completed

interventional

Mar 20166 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations